Part1 Considerations with Antibiotic Therapy
Chapter1 The Wonderful World of Microbiology
Chapter2 General Approach to Infectious Diseases
Chapter3 Antibiotic Pharmacokinetics
Chapter4 Antibiotic Pharmacodynamics
Chapter5 Adverse Consequences of Antibiotic Use
Chapter6 Antibiotic Resistance
Part2 Antibacterial Drugs
Chapter7 Beta-Lactams
Chapter8 Glycopeptides and Short-Acting Lipoglycopeptides
Chapter9 Long-Acting Glycopeptides
Chapter10 Fluoroquinolones
Chapter11 Aminoglycosides
Chapter12 Tetracyclines and Glycylcyclines
Chapter13 Macrolides and Ketolides
Chapter14 Oxazolidinones
Chapter15 Nitroimidazoles
Chapter16 Nitrofurans and Fosfomycin
Chapter17 Streptogramins
Chapter18 Cyclic Lipopeptides
Chapter19 Folate Antagonists
Chapter20 Lincosamides
Chapter21 Polymyxins
Chapter22 Fidaxomicin
Part3 Antimycobacterial Drugs
Chapter23 Antimycobacterial Drugs
Chapter24 Rifamycins
Chapter25 Isoniazid
Chapter26 Pyrazinamide
Chapter27 Ethambutol
Part4 Antifungal Drugs
Chapter28 Antifungal Drugs
Chapter29 Polyenes
Chapter30 Antifungal Antimetabolites
Chapter31 Azoles
Chapter32 Echinocandins
Part5 Antiviral Drugs
Chapter33 Antiviral Drugs
Chapter34 Anti-Herpes Simplex Virus and Varicella-Zoster Virus Agents
Chapter35 Anti-Cytomegalovirus Agents
Chapter36 Neuraminidase Inhibitors
Chapter37 Antiretrovial Drugs
Chapter38 Antiviral Interferons
Chapter39 Direct-Acting Anti-Hepatitis C Agents
Chapter40 Ribavirin
Chapter41 Hepatitis B Nucleoside Analogs
Part6 Antiparasitic Drugs
Chapter42 Antiparasitic Drugs
Chapter43 Quinolines
Chapter44 Atovaquone
Chapter45 Benzimidazoles
Chapter46 Pentamidine
Chapter47 Ivermectin
Appendix1 Selected Normal Human Flora
Appendix2 Clinically Useful Spectra of Activity
Appendix3 Empiric Regimens for Common Infections